Lab
Ascanio, Maria
Ascanio, Maria was paid $487K by Medicaid between Jan 2018 and Dec 2024, across 42 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 15% of everything it billed.
33Billing provider infoASCANIO, MARIA
YAUCO, PR 00698
YAUCO, PR 00698
33aNPI1609863521assigned 10/05/2005
33bProvider typeClinical Medical Laboratory
28Total paid$487K
24GClaims47,900
24DCodes billed42
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#261 of 777
Median peer was paid$278K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,284 | $53K | |
| 2019 | 6,217 | $50K | |
| 2020 | 5,451 | $49K | |
| 2021 | 7,355 | $84K | |
| 2022 | 7,282 | $102K | |
| 2023 | 7,613 | $78K | |
| 2024incomplete | 7,698 | $70K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 15% | 4,892 | 4,616 | $72K |
| 80061 | Lipid panel | 13% | 5,020 | 4,730 | $63K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 7,331 | 6,777 | $50K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.9% | 1,070 | 1,001 | $43K |
| 80053 | Comprehensive metabolic panel | 8.5% | 4,472 | 4,169 | $41K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8.4% | 1,620 | 1,490 | $41K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.8% | 1,370 | 1,262 | $33K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.8% | 2,678 | 2,512 | $23K |
| 81000 | 3.8% | 6,156 | 5,724 | $19K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.7% | 1,655 | 1,556 | $13K |
| 87088 | 2.5% | 1,590 | 1,483 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 232 | 223 | $12K |
30 more codes
| 82043 | 2.3% | 2,196 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.3% | 1,534 | $11K |
| 84439 | 2.0% | 1,184 | $9K | |
| 84153 | <1% | 300 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,684 | $4K |
| 82607 | <1% | 237 | $3K | |
| 86328 | <1% | 160 | $3K | |
| 87276 | <1% | 136 | $2K | |
| 87275 | <1% | 136 | $2K | |
| 86738 | <1% | 116 | $2K | |
| 86701 | <1% | 152 | $1K | |
| 82270 | <1% | 364 | $1K | |
| 82947 | <1% | 267 | $975.13 | |
| 82274 | <1% | 67 | $948.72 | |
| 86803 | <1% | 66 | $930.86 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 179 | $861.82 |
| 80050 | General health panel | <1% | 88 | $839.66 |
| 85730 | <1% | 108 | $533.98 | |
| 84436 | <1% | 81 | $511.29 | |
| 85651 | <1% | 146 | $492.51 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 36 | $469.99 |
| 85610 | <1% | 117 | $383.40 | |
| 82570 | <1% | 81 | $360.32 | |
| 84550 | <1% | 88 | $340.73 | |
| 84479 | <1% | 42 | $250.28 | |
| 81001 | <1% | 79 | $240.74 | |
| 86592 | <1% | 44 | $170.51 | |
| 82950 | <1% | 12 | $54.84 | |
| 3044F | 0% | 71 | $0.00 | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.